DiGeorge Syndrome Drug Market Share

North America Market Statistics

On the basis of regional analysis, the global DiGeorge syndrome drug market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region.

North America industry is estimated to hold largest revenue share by 2036, on the back of rising prevalence of the disorder. DiGeorge syndrome occurs in 1 in every 3000 to 6000 births in the U.S. and its proximity is equal between males and females. Additionally, the market is projected to witness significant growth owing to the growing medical advancements combined with efficient healthcare sector in the region. According to the World Health Organization (WHO), as of 2018, 16.416 % of the GDP was spent on the healthcare sector in North America. Moreover, increasing investments by the government on research and development activities for the development of newer treatment methods and more effective drugs are additional factors estimated to contribute towards the market growth in the forecast period.

APAC Market Analysis

The market in the Asia Pacific is anticipated to witness notable growth accounting to the increasing population and prevalence of DiGeorge syndrome in the region. Gradual, yet constant development in the public healthcare system in the APAC region also tends to positively affect the market growth.